Navigation Links
Misonix Reports First Quarter Fiscal 2011 Financial Results
Date:11/12/2010

FARMINGDALE, N.Y., Nov. 12, 2010 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, today reported financial results for the first fiscal quarter ending September 30, 2010.  Michael A. McManus, Jr., President and Chief Executive Officer, and Richard Zaremba, Senior VP and Chief Financial Officer, will host a conference call Monday, November 15, 2010 at 4:30 pm to discuss the Company's first fiscal quarter results.

The Company also reported the following financial and operational achievements:

  • A 24% increase in revenue for the first fiscal quarter 2011 compared with the first fiscal quarter 2010
  • Medical device products revenue for the first fiscal quarter 2011 increased 34% to $2.7 million compared with the first fiscal quarter 2010
  • Gross profit as a percentage of revenues increased to 50.3% in the first fiscal quarter 2011

    • Revenues for the three months ended September 30, 2010 were $3.3 million, a 24% increase when compared with $2.6 million for the same period in fiscal 2010.  Medical device product sales increased $689,000 or 34% to $2.7 million and laboratory and scientific product sales decreased $62,000 to $566,000 for the three months ended September 30, 2010.  The increase in revenue for medical device products during the three months ended September 30, 2010 was primarily attributable to sales of the Company's BoneScalpel™, Neuroaspirator, AutoSonix™ and SonicOne® products.

    Gross profit as a percentage of sales increased to 50.3% for the three months ended September 30, 2010 from 38.4% for the three months ended September 30, 2009.  Gross profit for medical device products increased to 54.7% for the three months ended September 30, 2010 from 45.4% for the three m
    '/>"/>

    SOURCE Misonix, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
    2. Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
    3. Misonix, Inc. Announces the Sale of Sonora Medical Systems for $8 Million
    4. Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland
    5. Misonix Announces New Distribution Agreement for Mexico
    6. Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern
    7. Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries
    8. Misonix Announces New Distribution Agreement for Peru
    9. Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE)
    10. Misonix Announces New Distribution Agreement for Argentina
    11. Misonix Announces New Distribution Agreement for Kingdom of Saudi Arabia
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- ... a new specialty pharmaceutical company dedicated to ... innovative injectable and sustained release drug therapies ... medical needs, today announced the acquisition of ... Technology®) platform and associated product pipeline. Acquisition ...
    (Date:6/19/2013)... YORK , June 19, 2013 ... brand new infographic summary of the results from ... a third of all respondents stated that CROs would be ... 50% of respondents will be running 6 or more clinical ... with the Clinical Trial Supply USA ...
    (Date:6/18/2013)... Valeant Pharmaceuticals International, Inc. (NYSE: ... that VPII Escrow Corp., a newly formed wholly owned ... of approximately $3.2 billion aggregate principal amount of senior ... in 2021 and in 2023, with final tranching determined ... the net proceeds from the offering, together with proceeds ...
    Breaking Medicine Technology:Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3
    (Date:6/19/2013)... AquaPrint Solutions in Thomson, IL is proud to ... newly-designed Harley Davidson motorcycle gas tank. A couple of weeks ... idea of taking a split tank motorcycle that had been ... into a work of art. , In October of ... seats that had been dipped in a water transfer printer ...
    (Date:6/19/2013)... 2013 Ethigen announced today the US ... service , providing next-generation sequencing (NGS) and rearrangement analysis ... part of an expanded hereditary cancer panel, including full ... links to cancer risk: MLH1, MSH2, MSH6, APC, MUTYH ... FH, FLCN, PDGFRA, and KIT. , The expanded ...
    (Date:6/19/2013)... When looking for ways to lose weight ... how to lose belly fat and excess fat in other ... Unnecessary and excess fat storage in these areas can be ... created their hCG diets to specially address these ... loss aids with nutritious meal plans and education on healthy ...
    (Date:6/19/2013)... (PRWEB) June 19, 2013 Walkingspree, a ... today announced the launch of its new Facebook App. ... motivate and inspire participants to reach their program fitness ... platform , Walkingspree clients are given more tools to ... member profile. , Corporate clients may choose whether or ...
    (Date:6/19/2013)... The website HealthNewsWires.com has recently published an informative article ... tips to manage and prevent the condition. , In ... defines insulin resistance as a condition that ... from the bloodstream. Glucose, or blood sugar, is ... systems of the body for normal function. The ...
    Breaking Medicine News(10 mins):Health News:AquaPrint Solutions Transforms Harley Davidson Gas Tank into a Work Of Art for Poopy’s Pub & Grub 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 2Health News:Ethigen Launches Next Generation (NGS) BRCA Testing With Expanded Hereditary Cancer Panel 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce A New Four Phase Program that Allows Patients to Lose Belly Fat, Thigh Fat and Underarm Fat Easily 2Health News:Walkingspree’s New Facebook Connectivity Boosts Accountability and Engagement 2Health News:Effects of Insulin Resistance and How to Increase Insulin Sensitivity Published in New Video by Health News Wire 2
    ... highlighted that patients who receive a hematopoietic stem cell transplant ... especially// if they are older during the time of the ... ,A peer-reviewed journal of the American Cancer ... allogeneic HSCT, the comparative risk of a second cancer is ...
    ... British government has been investing millions of pounds into ... to conduct a massive survey to determine how// accessible ... the intended survey, patients are going to be endowed ... contributing to the doctor’s income. ,The Prime Minister ...
    ... has planned to kill cats and dogs over fears of ... cull even dogs and cats so as to prevent further ... deadly H5N1 virus at a chicken farm last week. Animal ... extreme measure' because there was no scientific evidence that cats ...
    ... According to a new study published in January ... short-term structural changes in the cognitive areas of ... journal of the American Cancer Society, the researchers ... months of receiving adjuvant chemotherapy, significant regions of ...
    ... have observed an alarming trend in the kids, even those between ... teenagers. The physical and// behavioral changes which marks the teenage years ... of 8 to 12; so the sobriquet ‘tweens’, seems to fit ... fancy to own expensive items like cell phones and iPods. The ...
    ... in Australia to study the attitudes of people towards “tissue ... concerned about the// outcome of storage of tissue samples at ... found that ,most people were wary about biopsy tissue being ... possibly be used to produce human clones in the future. ...
    Cached Medicine News:Health News:Stem cell transplant recipients face significant risk of second cancer 2Health News:Britons soon will practise telling GPs how to practice 2Health News:Banking (T)issues : cloning issue surfaces 2
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: